G6PD Deficiency Linked to Childhood Disease Risk
In recent years, the intricate interplay between genetic disorders and pediatric health has ascended to the forefront of medical research, unveiling new pathways for understanding disease susceptibility in children. Among these genetic conditions, Glucose-6-Phosphate...
Hope and Uncertainty in Metastatic Uveal Melanoma
In recent years, the landscape of metastatic cancer treatment has undergone transformative change, largely due to the advent of immunotherapy and targeted therapies. These innovative treatments have offered extended survival prospects previously unimaginable for...
New Homocamptothecin Boosts Pancreatic Cancer Radiotherapy
In a groundbreaking study published in BMC Cancer, researchers have unveiled a promising new radiosensitizing agent, TOP-0618, a derivative of homocamptothecin, with significant potential to enhance radiotherapy outcomes in pancreatic cancer treatment. This discovery...
hnRNPL Drives PIK3CB Activation, Boosts Ovarian Cancer Glycolysis
In a groundbreaking study poised to redefine our understanding of ovarian cancer metabolism, researchers have unveiled a novel molecular mechanism by which cellular behaviors are orchestrated through the dynamic process of phase separation. This...
First Vascularized Organoid Model of Stem Cell-Derived Pancreatic Islets
An international team of researchers led by Max Delbrück Center Scientific Director Professor Maike Sander, MD, has for the first time developed an organoid model of human pluripotent stem cell-derived pancreatic islets (SC-islets) with...
Worldwide, Regional, and National Impact of Nontraumatic Subarachnoid Hemorrhage Unveiled
In a comprehensive new investigation unveiled at the European Stroke Organisation Conference 2025, medical researchers have shed light on the evolving global landscape of subarachnoid hemorrhage (SAH), a serious neurological condition with profound implications...
Zevra Cashes in on First FDA-Approved NPC Treatment with PRV
Neil F. McFarlane, Zevra Therapeutics President and CEO
After gaining FDA approval for Miplyffa® (arimoclomol) as the first-ever therapy indicated to treat Niemann-Pick disease type C (NPC), Zevra Therapeutics has cashed in on the regulatory...
Next-Generation Sequencing: The Smarter Path to Bulk Harvest Release Testing
REGISTER NOWBroadcast Date: Thursday, June 26, 2025Time: 8:00 am PT, 11:00 am ET, 17:00 CESTBulk harvest release testing for adventitious viruses is an integral part of biosafety for manufacturing biopharma products. Finding a testing...
Waters Acquires Halo Labs
Waters acquired Halo Labs, which specializes on imaging technologies to detect, identify, and count interfering materials (particles) in therapeutic products, such as cell, protein, and gene therapies.
The Aura platform from Halo Labs features a...
Optimizing Downstream Chromatography: Reducing Costs and Improving Efficiency
View eBook
The downstream chromatography industry is at the forefront of bioprocessing innovation, driving advancements in the purification and production of biopharmaceuticals. This eBook delves into the latest strategies and technologies revolutionizing downstream chromatography, offering...
